FDA Advisory Committee

Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug

Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug

21 hours ago   |   Xconomy

Sage Therapeutics is cutting workers who sell its only commercialized drug in a corporate reorganization that it says allows it to focus on clinical-stage compounds, including...
Read more ...

Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers

Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers

21 hours ago   |   Xconomy

Inovio Pharmaceuticals, one of the biotechs developing a vaccine to prevent COVID-19, has received the FDA's OK to start testing its candidate in healthy volunteers. The...
Read more ...

Mesa Biotech To Ship 10,000 Accula SARS-CoV-2 Tests This Week For 30 Minute Rapid Molecular Point of Care Diagnosis

1 day ago   |   San Diego Biotechnology

The only FDA authorized palm-sized system for COVID-19 testing enables broader use across healthcare facilities and closer to the patients with rapid results SAN DIEGO, April...
Read more ...

Ex-FDA chief says regulator needs to up pace on COVID-19 drugs

2 days ago   |   Fierce Biotech

Scott Gottlieb has called on the FDA to deploy regulatory tactics honed on rare and deadly cancers to help get a treatment for COVID-19 to market by the summer. Gottlieb thinks...
Read more ...

COVID-19: A Race to Frontline Testing: Apr 09, 2020

3 days ago   |   San Diego Biotechnology   |   2 articles

Mesa Biotech recently received FDA clearance to launch their point-of-care COVID-19 diagnostic test. Join us to hear Mesa Biotech CEO, Hong Cai, discuss the process to...
Read more ...

Zentalis Upsizes IPO, Raising $165M for Cancer Drug Clinical Trials

Zentalis Upsizes IPO, Raising $165M for Cancer Drug Clinical Trials

5 days ago   |   Xconomy

The global economic crash means the window for initial public stock offerings is all but closed but that didn't stop Zentalis Phamaceuticals from pushing through. The...
Read more ...

BioNTech, CureVac tell regulators to lower clinical trial bar if they want a COVID-19 vaccine quickly

5 days ago   |   Fierce Biotech   |   2 articles

Two German biotech companies who are at the start of a race to create new vaccines against the COVID-19 pandemic are warning the EMA and FDA they will need traditional clinical...
Read more ...

Celularity to Test Natural Killer Cell Therapy for Cancer Against COVID

Celularity to Test Natural Killer Cell Therapy for Cancer Against COVID

6 days ago   |   Xconomy   |   2 articles

Celularity, a New Jersey company developing experimental cancer treatments derived from human placentas, has received the FDA's blessing to kick off human testing of its lead...
Read more ...

COVID-19 vaccine packed into skin patch shows promise in mice

6 days ago   |   Fierce Biotech   |   3 articles

Researchers at the University of Pittsburgh School of Medicine developed a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity and that can be...
Read more ...

Giuliani-promoted COVID-19 therapy from Celularity nabs FDA speedy trial start

6 days ago   |   Fierce Biotech   |   2 articles

A new and unproved COVID-19 cell therapy from a New Jersey biotech has been given a quick trial approval by the FDA, coming just days after President Donald Trump's personal...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests

Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests

The financial markets may remain volatile but Keros Therapeutics managed to raise more money in its public market debut than it had initially planned. Late Tuesday the... Read more ...

Gilead Heightens Inflammatory Disease Focus With Second Genome Microbiome Deal

Gilead Heightens Inflammatory Disease Focus With Second Genome Microbiome Deal

Gilead Sciences has signed an agreement with South San Francisco biotech Second Genome to use its microbiome drug development expertise to advance the compounds it is... Read more ...

Organovo Future Unclear After Shareholders Reject Tarveda Merger

Organovo Future Unclear After Shareholders Reject Tarveda Merger

A planned merger between struggling 3-D “bioprinter” Organovo and Tarveda Therapeutics, a privately held cancer drug developer looking to join the public markets through a... Read more ...

In Battle Against COVID-19 Pandemic, Scientists Turn to PacBio Sequencing

In Battle Against COVID-19 Pandemic, Scientists Turn to PacBio Sequencing

Image by Miroslava Chrienova from Pixabay Our team is proud to announce that PacBio has been working closely with customers to help in the fight against the COVID-19 pandemic... Read more ...

Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics

Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics

Some diseases have proven difficult to address using conventional tools of drug discovery that target disease-causing proteins. Roche is placing a $190 million bet on Arrakis... Read more ...

Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers

Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers

Inovio Pharmaceuticals, one of the biotechs developing a vaccine to prevent COVID-19, has received the FDA's OK to start testing its candidate in healthy volunteers. The... Read more ...

Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug

Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug

Sage Therapeutics is cutting workers who sell its only commercialized drug in a corporate reorganization that it says allows it to focus on clinical-stage compounds, including... Read more ...

Creating Consistent Value in Biotech Without Diluting Stakeholders

Creating Consistent Value in Biotech Without Diluting Stakeholders

One of the greatest challenges for pre-commercial biotech companies is consistently generating capital necessary for operating costs and for R&D of new products that provide... Read more ...

Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13

Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13

In the Boston biotech hub, much progress has been made advancing digital health, but significant scientific, technological, financial, and regulatory challenges remain. Join us... Read more ...

Methylation-driven model for analysis of dinucleotide evolution in genomes

CpGs, the major methylation sites in vertebrate genomes, exhibit a high mutation rate from the methylated form of CpG to TpG/CpA and, therefore, influence the evolution of... Read more ...